Overwhelmingly, the evidence collected over the past 15 years has failed to yield any evidence of significant harm, including serious neurodevelopmental disorders, from use of thimerosal in vaccines. Dozens of studies from countries around the world have supported the safety of thimerosal-containing vaccines. Specifically, the Institute of Medicine, and others have concluded that the evidence favors rejection of a link between thimerosal and autism. [6] [7] [8] [9] [10] [11] [12] Careful studies of the risk of other serious neurodevelopmental disorders have failed to support a causal link with thimerosal. [13] [14] [15] [16] [17] In May 2002, the American Academy of Pediatrics retired its 1999 statement on thimerosal after evaluating new studies. 3, 18 The original decision is explained in an accompanying commentary in this issue by Dr Louis Z. Cooper and Dr Samuel Katz. 19 Had the evidence that is available now been available in 1999, the policy reducing thimerosal use would likely have not been implemented. Furthermore, in 2008 the World Health Organization (WHO) endorsed the use of thimerosal in vaccines. 20 Because of the well-known neurotoxic effects of methyl mercury and the conversion of mercury to methyl mercury in aquatic organisms, the United Nations Environmental Program (UNEP) is working admirably to This is an exciting time for global immunization programs. Global immunization efforts are being supported worldwide by many organizations, including the US government as both humanitarian and protective measures. 30 As advocates for the health of all children, we strongly support these efforts also. Immunization prevents ∼2.5 million deaths a year globally. Millions more deaths could be prevented if global immunization efforts are bolstered. 31 The preponderance of available evidence has failed to demonstrate serious harm associated with thimerosal in vaccines. As such, we extend our strongest support to the recent Strategic Advisory Group of Experts recommendations to retain the use of thimerosal in the global vaccine supply.
